Filter
104
Text search:
Moderna
vaccine
Featured
Recommendations
14
Language
Document type
Fact sheets
30
Studies & Reports
27
Guidelines
22
Manuals
6
Resource Platforms
5
Training Material
4
Online Courses
3
Infographics
2
Strategic & Response Plan
2
No document type
2
Videos
1
Countries / Regions
Germany
9
Ukraine
5
Argentina
4
Middle East and North Africa
4
Paraguay
4
China
3
Brazil
3
Russia
3
Global
3
Colombia
2
Ecuador
2
Latin America and the Carribbean
2
Guinea-Bissau
1
Ghana
1
Haiti
1
Philippines
1
Kenya
1
South Africa
1
Mozambique
1
Angola
1
Chile
1
East and Southern Africa
1
West and Central Africa
1
South–East Asia Region
1
Western and Central Europe
1
Africa
1
Eastern Europe
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
43
Clinical Guidelines
3
Key Resources
3
Annual Report MEDBOX
1
Public Health
1
Pharmacy & Technologies
1
Toolboxes
COVID-19
89
Refugee
3
Conflict
2
Health Financing Toolbox
2
Rapid Response
1
TB
1
Pharmacy
1
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards
the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized
...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized i
...
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment
...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have ho
...
These are standing orders for eligible nurses and healthcare professionals to administer the Moderna COVID-19 vaccine to persons 18 years of age and older
Introduction: Considering the global prevalence of coronavirus disease 2019 (COVID-19), a vaccine is being developed to control the disease as a complementary solution to hygiene measures—and better, in social terms, than social distancing. Given
...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored
...
This training module is designed to equip HWs with knowledge and communication skills to build their confidence and support them in their ability to promote acceptance of COVID-19 vaccination among other HWs.
The guide explains how vaccines work and answers your common questions as well as providing up-to-date information on the current approved COVID-19 vaccinations in the UK.
This guide was written in January 2021 and updated in March 2021 and is accurate at the time of publishing. Information will b
...
first issued 18 August 2022
FEY ENFOMASYON POU MOUN K’AP RESEVWA AVEK MOUN K’AP BAY SWEN OTORIZASYON POU ITILIZASYON IJANS (EUA) POU VAKSIN MODERNA COVID-19 POU ANPECHE CORONAVIRUSDISEASE 2019
(COVID-19) NAN PERSONN 18 ANE AK PI GRAN
COVID-19 vaccine hesitancy is currently one of the main obstacles to worldwide herd immunity and socioeconomic recovery. Because vaccine coverage can vary between and within countries, it is importa
...
CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to mobilise a portion of this $3.5 billion in 2021. We have already launched R&D programmes to initiate de
...
